Skip to main content
Log in

In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of telmisartan

  • Original Article
  • Published:
Journal of Inclusion Phenomena and Macrocyclic Chemistry Aims and scope Submit manuscript

Abstract

Telmisartan (TEL) is a BCS Class II drug having dissolution rate limited bioavailability. The aim of work was to enhance the solubility of TEL so that bioavailability problems are solved. β-Cyclodextrin (β-CD) based nanosponges (NSs) were formed by cross-linking β-CD with carbonate bonds, which were porous as well as nanosized. Drug was incorporated by solvent evaporation method. The effect of ternary component alkalizer (NaHCO3) on solubility of TEL was studied. In order to find out the solubilization efficiency of NS, phase solubility study was carried out. Saturation solubility and in vitro dissolution study of β-CD complex of TEL was compared with plain TEL and NS complexes of TEL. The NS and NS complexes of TEL were characterized by differential scanning calorimetry, powder X-ray diffraction, Fourier transform infrared spectroscopy, nuclear magnetic resonance and scanning electron microscope. It was found that solubility of TEL was increased by 8.53-fold in distilled water; 3.35-fold in 0.1 N HCl and 4.66-fold in phosphate buffer pH 6.8 by incorporating NaHCO3 in drug–NS complex than TEL. It was found that the NaHCO3 in NS based complex synergistically enhanced dissolution of TEL by modulating microenvironmental pH and by changing amorphization of the drug. The highest solubility and in vitro drug release was observed in inclusion complex prepared from NS and NaHCO3. An increase of 54.4 % in AUC was seen in case the ternary NS complex whereas β-CD ternary complex exhibited an increase of 79.65 %.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Rossi, S., Ferrari, F., Bonferoni, M.C., Caramella, C.: Characterization of chitosan hydrochloride–mucin interaction by means of viscosimetric and turbidimetric measurements. Eur. J. Pharm. Sci. 10, 251–257 (2000)

    Article  CAS  Google Scholar 

  2. Rekharsky, M.V., Inove, Y.: Complexation thermodynamics of cyclodextrins. Chem. Rev. 98, 1875–1918 (1998)

    Article  CAS  Google Scholar 

  3. Connors, K.A.: The stability of cyclodextrin complexes in solution. Chem. Rev. 97, 1325–1358 (1997)

    Article  CAS  Google Scholar 

  4. Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743–1754 (1998)

    Article  CAS  Google Scholar 

  5. Cavalli, R., Trotta, F., Tumiatti, W.: Cyclodextrin-based nanosponges for drug delivery. J. Incl. Phenom. Macrocycl. Chem. 56, 209–213 (2006)

    Article  CAS  Google Scholar 

  6. Swaminathan, S., Pastero, L., Serpe, L., Trotta, F., Vavia, P., Aquilano, D., Trotta, M., Zara, G., Cavalli, R.: Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur. J. Pharm. Biopharm. 74, 193–201 (2010)

    Article  CAS  Google Scholar 

  7. Velasquez, M.T.: Angiotensin II receptor blockers, a new class of antihypertensive drugs. Arch. Fam. Med. 5, 351–356 (1996)

    Article  CAS  Google Scholar 

  8. Nakatani, M., Takeshi, S., Ohki, T., Toyoshima, K.: Solid TEL pharmaceutical formulations. US Patent 2004/0110813 A1, 2004

  9. Phuong, H.L.T., Huyen, T.T., Beom-Jin, L.: Modulation of microenvironmental pH and crystallinity of ionizable TEL using alkalizers in solid dispersions for controlled release. J. Control. Release 129, 59–65 (2008)

    Article  Google Scholar 

  10. Trotta, F., Tumiatti, W.: Cyclodextrin-based NS as a vehicle for antitumoral drugs. World Patent Number WO/2009/003656, 2009

  11. Higuchi, T., Connors, K.: Phase solubility techniques. In: Reilly, C. (ed.) Advances in Analytical Chemistry and Instrumentation, pp. 117–212. Wiley–Interscience, New York (1965)

    Google Scholar 

  12. Swaminathan, S., Vavia, P.R., Trotta, F., Torne, S.: Formulation of betacyclodextrin based nanosponges of itraconazole. J. Incl. Phenom. Macrocycl. Chem. 57, 89–94 (2007)

    Article  CAS  Google Scholar 

  13. Marques, M.: Dissolution media simulating fasted and fed state. Dissolution Technol. 11(2), 16 (2004)

    Google Scholar 

  14. Shimasaki, M., Yamashit, K.: Pharmacokinetics of 14C-TEL (2): plasma concentration and distribution of 14C-TEL after repeated oral administration to rats. Xenobiol. Metab. Dispos. 14, 432–436 (1999)

    CAS  Google Scholar 

  15. Brahmankar, D.M., Jaiswal, S.B.: Biopharmaceutics and Pharmacokinetics: A Treatise. Vallabh Prakashan, New Delhi (2005)

    Google Scholar 

  16. Chada, R., Kashid, N., Saini, A.: Account of analytical techniques employed for the determination of thermodynamics of inclusion complexation of drugs with cyclodextrins. J. Sci. Ind. Res. 63, 211–229 (2004)

    Google Scholar 

Download references

Conflicts of interest

The author reports no conflicts of interest financial or otherwise.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monica Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rao, M., Bajaj, A., Khole, I. et al. In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of telmisartan. J Incl Phenom Macrocycl Chem 77, 135–145 (2013). https://doi.org/10.1007/s10847-012-0224-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10847-012-0224-7

Keywords

Navigation